XYL

SEC source: 0001209191-18-009106 · doc4.xml · nonDerivative · entry 2

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,385

F1 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $71.85 to $71.86 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-18-009106 · doc4.xml · nonDerivative · entry 1

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-066695 · doc4.xml · derivative · entry 7

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,120 shares

Expires 2018-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-066695 · doc4.xml · nonDerivative · entry 4

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,131

F3 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $68.00 to $68.34 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-066695 · doc4.xml · nonDerivative · entry 3

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,251

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017.

SEC source: 0001209191-17-066695 · doc4.xml · derivative · entry 6

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,120

Underlying: Common Stock · 5,019 shares

Expires 2018-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-066695 · doc4.xml · nonDerivative · entry 2

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,131

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $68.00 to $68.02 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-066695 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017.

SEC source: 0001209191-17-066603 · doc4.xml · nonDerivative · entry 1

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,975

F1 · shares: Reflects the sale of shares of common stock to cover the tax liability incident to the vesting of restricted stock units granted on December 18, 2014 under the Xylem 2011 Omnibus Incentive Plan.

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $67.70 to $67.83 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-066272 · doc4.xml · derivative · entry 4

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,139

Underlying: Common Stock · 47,712 shares

Expires 2018-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-066272 · doc4.xml · nonDerivative · entry 2

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,131

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $68.00 to $68.35 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-066272 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017.

SEC source: 0001209191-17-065805 · doc4.xml · derivative · entry 4

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,851

Underlying: Common Stock · 200 shares

Expires 2018-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-065805 · doc4.xml · nonDerivative · entry 2

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,131

SEC source: 0001209191-17-065805 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017.

SEC source: 0001209191-17-065495 · doc4.xml · derivative · entry 4

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,051

Underlying: Common Stock · 196 shares

Expires 2018-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-065495 · doc4.xml · nonDerivative · entry 2

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,131

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $68.07 to $68.39 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-065495 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,327

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017.

SEC source: 0001209191-17-060153 · doc4.xml · nonDerivative · entry 1

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,385

F1 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $66.36 to $66.50 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-059710 · doc4.xml · derivative · entry 4

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,247

Underlying: Common Stock · 50,000 shares

Expires 2018-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-059710 · doc4.xml · nonDerivative · entry 2

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,131

F1 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $66.0 to $66.7 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-059710 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,831

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-059426 · doc4.xml · derivative · entry 7

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,017

Underlying: Common Stock · 10,000 shares

Expires 2024-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-059426 · doc4.xml · derivative · entry 6

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,078 shares

Expires 2023-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-059426 · doc4.xml · nonDerivative · entry 5

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,909

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $65.51 to $66.18 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-059426 · doc4.xml · nonDerivative · entry 4

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,901

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $65.66 to $65.97 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-059426 · doc4.xml · nonDerivative · entry 3

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,901

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-059426 · doc4.xml · nonDerivative · entry 2

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,901

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $65.50 to $66.05 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-17-059426 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,979

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-058525 · doc4.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,993

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on October 29, 2014 under the Xylem 2011 Omnibus Incentive Plan.

SEC source: 0001209191-17-051150 · doc4.xml · nonDerivative · entry 1

Stellato Paul A · CIK 0001714585 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,682

F1 · shares: Reflects an award of restricted stock units which are scheduled to vest in three equal annual installments beginning on September 1, 2018.

SEC source: 0001209191-18-009997 · doc5.xml · nonDerivative · entry 2

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Tambakeras Family Trust

Disclosed balance after: 27,964

F1 · balance_after: On August 23, 2017, 9512 shares of Xylem Inc. common stock were gifted to the reporting person's revocable family trust.

SEC source: 0001209191-18-009997 · doc5.xml · nonDerivative · entry 1

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,070

SEC source: 0001209191-17-049566 · doc4.xml · nonDerivative · entry 1

Beliveau-Dunn Jeanne · CIK 0001714894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,752

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholders' meeting.

SEC source: 0001209191-17-048377 · doc4.xml · nonDerivative · entry 1

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,303

F1 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $60.06 to $60.25 per share. Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-047830 · doc4.xml · nonDerivative · entry 1

Tarapore Kairus · CIK 0001383582 · SVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,983

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on August 3, 2015 under the Xylem 2011 Omnibus Incentive Plan.

F2 · balance_after: Additional shares also accrued through a qualified DRIP.

SEC source: 0001209191-17-042554 · doc4.xml · derivative · entry 7

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,933 shares

Expires 2018-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-042554 · doc4.xml · nonDerivative · entry 4

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,831

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016.

F3 · price: This price represents the approximate weighted average price per Share of the Issuer that were executed at prices ranging from $55.00 to $55.30 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-042554 · doc4.xml · nonDerivative · entry 3

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016.

SEC source: 0001209191-17-042554 · doc4.xml · derivative · entry 6

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,933

Underlying: Common Stock · 56,199 shares

Expires 2018-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-17-042554 · doc4.xml · nonDerivative · entry 2

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,831

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016.

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $55.00 to $55.02 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-17-042554 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,030

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016.

SEC source: 0001209191-17-031670 · doc4.xml · nonDerivative · entry 1

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,582

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholders' meeting.

SEC source: 0001209191-17-031659 · doc4.xml · nonDerivative · entry 1

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,885

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholders' meeting.

SEC source: 0001209191-17-031653 · doc4.xml · nonDerivative · entry 1

Peribere Jerome A · CIK 0001484527 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,469

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholder's meeting.

F2 · balance_after: Additional shares also accrued through a qualified DRIP.

SEC source: 0001209191-17-031657 · doc4.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,604

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholder's meeting.

SEC source: 0001209191-17-031669 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,831

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholder's meeting.

SEC source: 0001209191-17-031655 · doc4.xml · nonDerivative · entry 1

MOHAPATRA SURYA N · CIK 0001222671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,469

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholder's meeting.

SEC source: 0001209191-17-031666 · doc4.xml · nonDerivative · entry 1

FRIEL ROBERT F · CIK 0001224110 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,811

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholder's meeting.

F2 · balance_after: Additional shares also accrued through a qualified DRIP.

SEC source: 0001209191-17-031652 · doc4.xml · nonDerivative · entry 2

Jakobsson Sten E · CIK 0001532863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,166

F2 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2018 annual shareholder's meeting.